Cargando…
Dysbiosis patterns during re-induction/salvage versus induction chemotherapy for acute leukemia
Acute leukemia (AL) patients undergoing intensive induction chemotherapy develop severe gut dysbiosis, placing them at heightened risk for infectious complications. Some AL patients will undergo “repeat therapy” (re-induction or salvage) due to persistent or relapsed disease. We hypothesized that pr...
Autores principales: | Rashidi, Armin, Kaiser, Thomas, Shields-Cutler, Robin, Graiziger, Carolyn, Holtan, Shernan G., Rehman, Tauseef Ur, Wasko, Justin, Weisdorf, Daniel J., Dunny, Gary, Khoruts, Alexander, Staley, Christopher |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group UK
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6465677/ https://www.ncbi.nlm.nih.gov/pubmed/30988420 http://dx.doi.org/10.1038/s41598-019-42652-6 |
Ejemplares similares
-
Vancomycin-resistance gene cluster, vanC, in the gut microbiome of acute leukemia patients undergoing intensive chemotherapy
por: Rashidi, Armin, et al.
Publicado: (2019) -
Gut microbiota response to antibiotics is personalized and depends on baseline microbiota
por: Rashidi, Armin, et al.
Publicado: (2021) -
Effect of COVID-19 precautions on the gut microbiota and nosocomial infections
por: Rashidi, Armin, et al.
Publicado: (2021) -
Compilation of longitudinal gut microbiome, serum metabolome, and clinical data in acute myeloid leukemia
por: Rashidi, Armin, et al.
Publicado: (2022) -
75200 Fecal Microbiota Transplantation to Prevent Infections in Patients with Acute Myeloid Leukemia: A Double-Blind Randomized Placebo-Controlled Phase 2 Clinical Trial
por: Ebadi, Armin Rashidiryam, et al.
Publicado: (2021)